Cargando…
Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos
Cohesin rings interact with DNA and modulate the expression of thousands of genes. NIPBL loads cohesin onto chromosomes, and WAPL takes it off. Haploinsufficiency for NIPBL causes a developmental disorder, Cornelia de Lange syndrome (CdLS), that is modeled by Nipbl(+/−) mice. Mutations in WAPL have...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710879/ https://www.ncbi.nlm.nih.gov/pubmed/36449618 http://dx.doi.org/10.1126/sciadv.add4136 |
_version_ | 1784841456669687808 |
---|---|
author | Kean, Connor M. Tracy, Christopher J. Mitra, Apratim Rahat, Beenish Van Winkle, Matthew T. Gebert, Claudia M. Noeker, Jacob A. Calof, Anne L. Lander, Arthur D. Kassis, Judith A. Pfeifer, Karl |
author_facet | Kean, Connor M. Tracy, Christopher J. Mitra, Apratim Rahat, Beenish Van Winkle, Matthew T. Gebert, Claudia M. Noeker, Jacob A. Calof, Anne L. Lander, Arthur D. Kassis, Judith A. Pfeifer, Karl |
author_sort | Kean, Connor M. |
collection | PubMed |
description | Cohesin rings interact with DNA and modulate the expression of thousands of genes. NIPBL loads cohesin onto chromosomes, and WAPL takes it off. Haploinsufficiency for NIPBL causes a developmental disorder, Cornelia de Lange syndrome (CdLS), that is modeled by Nipbl(+/−) mice. Mutations in WAPL have not been shown to cause disease or gene expression changes in mammals. Here, we show dysregulation of >1000 genes in Wapl(Δ/+) embryonic mouse brain. The patterns of dysregulation are highly similar in Wapl and Nipbl heterozygotes, suggesting that Wapl mutations may also cause human disease. Since WAPL and NIPBL have opposite effects on cohesin’s association with DNA, we asked whether decreasing Wapl dosage could correct phenotypes seen in Nipbl(+/−) mice. Gene expression and embryonic growth are partially corrected, but perinatal lethality is not. Our data are consistent with the view that cohesin dynamics play a key role in regulating gene expression. |
format | Online Article Text |
id | pubmed-9710879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-97108792022-12-07 Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos Kean, Connor M. Tracy, Christopher J. Mitra, Apratim Rahat, Beenish Van Winkle, Matthew T. Gebert, Claudia M. Noeker, Jacob A. Calof, Anne L. Lander, Arthur D. Kassis, Judith A. Pfeifer, Karl Sci Adv Biomedicine and Life Sciences Cohesin rings interact with DNA and modulate the expression of thousands of genes. NIPBL loads cohesin onto chromosomes, and WAPL takes it off. Haploinsufficiency for NIPBL causes a developmental disorder, Cornelia de Lange syndrome (CdLS), that is modeled by Nipbl(+/−) mice. Mutations in WAPL have not been shown to cause disease or gene expression changes in mammals. Here, we show dysregulation of >1000 genes in Wapl(Δ/+) embryonic mouse brain. The patterns of dysregulation are highly similar in Wapl and Nipbl heterozygotes, suggesting that Wapl mutations may also cause human disease. Since WAPL and NIPBL have opposite effects on cohesin’s association with DNA, we asked whether decreasing Wapl dosage could correct phenotypes seen in Nipbl(+/−) mice. Gene expression and embryonic growth are partially corrected, but perinatal lethality is not. Our data are consistent with the view that cohesin dynamics play a key role in regulating gene expression. American Association for the Advancement of Science 2022-11-30 /pmc/articles/PMC9710879/ /pubmed/36449618 http://dx.doi.org/10.1126/sciadv.add4136 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Kean, Connor M. Tracy, Christopher J. Mitra, Apratim Rahat, Beenish Van Winkle, Matthew T. Gebert, Claudia M. Noeker, Jacob A. Calof, Anne L. Lander, Arthur D. Kassis, Judith A. Pfeifer, Karl Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos |
title | Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos |
title_full | Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos |
title_fullStr | Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos |
title_full_unstemmed | Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos |
title_short | Decreasing Wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in Nipbl(+/−) embryos |
title_sort | decreasing wapl dosage partially corrects embryonic growth and brain transcriptome phenotypes in nipbl(+/−) embryos |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710879/ https://www.ncbi.nlm.nih.gov/pubmed/36449618 http://dx.doi.org/10.1126/sciadv.add4136 |
work_keys_str_mv | AT keanconnorm decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT tracychristopherj decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT mitraapratim decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT rahatbeenish decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT vanwinklematthewt decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT gebertclaudiam decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT noekerjacoba decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT calofannel decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT landerarthurd decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT kassisjuditha decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos AT pfeiferkarl decreasingwapldosagepartiallycorrectsembryonicgrowthandbraintranscriptomephenotypesinnipblembryos |